ArticleCancer immunology research2024

Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.

Christianne Groeneveldt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.